BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18665755)

  • 1. The impact of PET with 18FDG in radiotherapy treatment planning and in the prediction in patients with cervix carcinoma: results of pilot study.
    Dolezelova H; Slampa P; Ondrova B; Gombosova J; Sovadinova S; Novotny T; Bolcak K; Ruzickova J; Hynkova L; Forbelska M
    Neoplasma; 2008; 55(5):437-41. PubMed ID: 18665755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of PET in the diagnosis and prediction of the treatment response in patients with cervical carcinoma treated with radiotherapy--results of pilot study].
    Dolezelová H; Slampa P; Ondrová B; Bolcák K; Gombosová J; Sovadinová S; Novotný T; Růzicková J; Hynková L; Opletal P; Forbelská M
    Klin Onkol; 2008; 21(2):66-70. PubMed ID: 19102214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The impact of PET in radiotherapy of the cervical carcinoma--results of pilot study].
    Dolezelová H; Slampa P; Bolcák K; Gombosová J; Ondrová B; Novotný T; Hynková L; Růzicková J; Forbelská M
    Ceska Gynekol; 2008 Jun; 73(3):135-40. PubMed ID: 18646663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
    Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
    J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix.
    Lin LL; Mutic S; Malyapa RS; Low DA; Miller TR; Vicic M; Laforest R; Zoberi I; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1494-501. PubMed ID: 16154713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer.
    Schwarz JK; Lin LL; Siegel BA; Miller TR; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1502-7. PubMed ID: 18538498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.
    Magné N; Chargari C; Vicenzi L; Gillion N; Messai T; Magné J; Bonardel G; Haie-Meder C
    Cancer Treat Rev; 2008 Dec; 34(8):671-81. PubMed ID: 18849119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
    Yildirim Y; Sehirali S; Avci ME; Yilmaz C; Ertopcu K; Tinar S; Duman Y; Sayhan S
    Gynecol Oncol; 2008 Jan; 108(1):154-9. PubMed ID: 17945337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV status does not have an impact on positron emission tomography-computed tomography (PET-CT) findings or radiotherapy treatment recommendations in patients with locally advanced cervical cancer.
    Simonds H; Botha MH; Ellmann A; Warwick J; Doruyter A; Neugut AI; Van Der Merwe H; Jacobson JS
    Int J Gynecol Cancer; 2019 Oct; 29(8):1252-1257. PubMed ID: 31413068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value.
    Sakurai H; Suzuki Y; Nonaka T; Ishikawa H; Shioya M; Kiyohara H; Katoh H; Nakayama Y; Hasegawa M; Nakano T
    Gynecol Oncol; 2006 Mar; 100(3):601-7. PubMed ID: 16257440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET in cervical cancer: staging, re-staging and follow-up.
    Bjurberg M; Kjellén E; Ohlsson T; Ridderheim M; Brun E
    Acta Obstet Gynecol Scand; 2007; 86(11):1385-91. PubMed ID: 17851810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer.
    Lin LL; Yang Z; Mutic S; Miller TR; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):177-81. PubMed ID: 16545921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
    Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of PET/CT in the evaluation of cervical cancer.
    Jover R; Lourido D; Gonzalez C; Rojo A; Gorospe L; Alfonso JM
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S55-9. PubMed ID: 18667229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
    Chao A; Ho KC; Wang CC; Cheng HH; Lin G; Yen TC; Lai CH
    Gynecol Oncol; 2008 Aug; 110(2):172-8. PubMed ID: 18499238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the use PET for radiation therapy planning in patients with cervical cancer: a systematic review.
    Salem A; Salem AF; Al-Ibraheem A; Lataifeh I; Almousa A; Jaradat I
    Hematol Oncol Stem Cell Ther; 2011; 4(4):173-81. PubMed ID: 22198188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
    Vrieze O; Haustermans K; De Wever W; Lerut T; Van Cutsem E; Ectors N; Hiele M; Flamen P
    Radiother Oncol; 2004 Dec; 73(3):269-75. PubMed ID: 15588870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
    Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
    Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.